| DOI | Resolve DOI: https://doi.org/10.1007/978-90-481-3419-9_77 |
|---|
| Author | Search for: Dormond, E.1; Search for: Meneses-Acosta, A.1; Search for: Jacob, D.1; Search for: Durocher, Y.1; Search for: Perrier, M.; Search for: Kamen, A.1 |
|---|
| Name affiliation | - National Research Council of Canada. NRC Biotechnology Research Institute
|
|---|
| Format | Text, Article |
|---|
| Conference | 20th ESACT Meeting, June 17-20, 2007, Dresden, Germany |
|---|
| Subject | helper-dependent adenoviral vector; HEK 293; PEI-transfection; suspension cells; bioreactor |
|---|
| Abstract | Helper-dependent adenoviral vector has demonstrated a high therapeutic potential; however, the poor efficiency of the actual production process hampers further large-scale clinical evaluation. In this work, we evaluated the adenofection protocol, an efficient polyethylenimine transfection strategy, for HDV production. Optimized conditions of PEI-adenofection were used to generate HDV at 3-L bioreactor scale. This process strategy realized in suspension reduced process duration and therefore ensured production of high-quality vector stock. |
|---|
| Publication date | 2010-06-02 |
|---|
| Publisher | Springer |
|---|
| In | |
|---|
| Series | |
|---|
| Language | English |
|---|
| Peer reviewed | Yes |
|---|
| NPARC number | 23001980 |
|---|
| Export citation | Export as RIS |
|---|
| Report a correction | Report a correction |
|---|
| Record identifier | f7673588-623f-4a5b-8cd5-0cedb223d1d6 |
|---|
| Record created | 2017-07-12 |
|---|
| Record modified | 2020-04-17 |
|---|
